30Sep 2019

OXIDATIVE STRESS AND GENETIC INSTABILITIES IN POLYCYSTIC OVARIAN SYNDROME.

  • Research Scholar, Meenakshi University, West K K Nagar, Chennai, Tamil Nadu, India.
  • Department of physiology, K S Hegde Medical Academy, Mangalore, Karnataka, India.
  • Department of physiology, Meenakshi Medical College, Research Institute, Kanchipuram, Tamil Nadu, India.
  • Genetika, Centre for Advanced Genetic Studies, Pettah P O, Thiruvananthapuram - 695024, Kerala.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

The polycystic ovary syndrome (PCOS) is a hyper androgenic disorder associated with chronic oligo-anovulation and polycystic ovarian morphology. Women with PCOS have an increased risk of miscarriage, gestational diabetes, preeclampsia and preterm labour. The pathogenesis of PCOS is however unclear but is thought to be multifactorial consisting of endocrine, metabolic, genetic and environmental factors. The present study consists of 40 study subjects with PCOS and 35 healthy control subjects. Detailed demographic, clinical and lifestyle characteristics were recorded and compared with other clinical parameters. The association of various physiological and lifestyle factors which leads to oxidative stress was analysed by evaluating MDA concentration and subsequent DNA damages, if any, was quantified by Cytokinesis-block Micronuclei (CBMN) assay. Study subjects demonstrated a statistically significant increased serum MDA level and mean CBMN frequency than the control subjects. Subjects with abnormal biochemical, physiological and endocrinological characters showed increased mean CBMN frequency. These findings denoted that there is a strong evidence of genetic instability among subjects with PCOS. Hence the study can be concluded that, oxidative stress and somatic DNA damages may play a major role in the risk of PCOS and further complications. Optimal metabolic control and lifestyle modification can reduce the unwanted clinical symptoms of infertility. Healthy lifestyle factors, including exercise, are associated significantly with reduced DNA damages.

  1. ArunWillam, Viji Krishnan, Deeepthi, T., Sreesha, S.R., Dinesh Roy D., ?Androgen Excess and Genetic Instabilities in Anovulatory Infertility?, Indian journal of applied research, vol.6, no.4, 2016, pp. 324-327.
  2. Azziz R, Carmina E, Dewailly, et al. Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline.?Journal of Clinical Endocrinology & Metabolism.?2006;91:4237?4245.
  3. Azziz, R., Woods, K.S., Reyna, R., Key, T.J., Knochenhauer, E.S. and Yildiz, B.O., 2004. The prevalence and features of the polycystic ovary syndrome in an unselected population.?The Journal of Clinical Endocrinology & Metabolism,?89(6), pp.2745-2749.
  4. Baillargeon, J.P., Nestler, J.E., Ostlund, R.E., Apridonidze, T. and Diamanti-Kandarakis, E., 2008. Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism.?Human Reproduction,?23(6), pp.1439-1446.
  5. Boomsma, C.M., Eijkemans, M.J.C., Hughes, E.G., Visser, G.H.A., Fauser, B.C.J.M. and Macklon, N.S., 2006. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome.?Human reproduction update,?12(6), pp.673-683.
  6. Josey Ann Jijo, Arun William, Aneesh P, Leenamma Joseph, Lija L Raju, Viji Krishnan and Dinesh Roy D., ?Cytogenetics and molecular genetics on female infertility with special emphasis on polycystic ovarian syndrome?, international journal of advanced research (IJAR), vol.5, no. 2, 2017, pp.483-488.
  7. Kabel, A.M., 2016. Polycystic ovarian syndrome: insights into pathogenesis, diagnosis, prognosis, pharmacological and non-pharmacological treatment.?J Pharma Reports,?1(103), p.2.
  8. Kuscu NK, Var A. Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome.?ActaObstetGynecol Scand.?2009;88:612?7.
  9. Mokhtar, S., Hassan, H.A., Mahdy, N., Elkhwsky, F. and Shehata, G., 2006. Risk factors for primary and secondary female infertility in Alexandria: a hospital-based case-control study.?J Med Res Inst,?27, pp.251-61.
  10. Murri M, Luque-Ram?rez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): A systematic review and meta-analysis.?Human Reprod Update.?2013; 19:268?88.
  11. Norman, R.J., Davies, M.J., Lord, J. and Moran, L.J., 2002. The role of lifestyle modification in polycystic ovary syndrome.?Trends in Endocrinology & Metabolism,?13(6), pp.251-257.
  12. Stein, I.F., 1935. Amenorrhea associated with bilateral polycystic ovaries.?Am J ObstetGynecol,?29, pp.181-191.
  13. Tehrani, F.R. and Behboudi-Gandevani, S., 2015. Polycystic ovary syndrome.?Contemporary Gynecologic Practice, pp.79-89.
  14. Umland, E.M., Weinstein, L.C., Buchanan, E.M., 2011, ʽMenstruation-related disorder?, In:DiPiro JT, Talbert RT, Yee GC, et al.,editors. Pharmacotheraphy: A Pathophysiologic Approach 8th New York: McGraw-Hilll, pp. 1393.
  15. Wild, R.A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H.F., Futterweit, W., Lobo, R., Norman, R.J., Talbott, E. and Dumesic, D.A., 2010. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.?The Journal of Clinical Endocrinology & Metabolism,?95(5), pp.2038-2049.

[Aneesh P, AP Krishna, E Kayalvizhi, Drisya K, Anaswara AA and Dinesh Roy D. (2019); OXIDATIVE STRESS AND GENETIC INSTABILITIES IN POLYCYSTIC OVARIAN SYNDROME. Int. J. of Adv. Res. 7 (Sep). 1336-1340] (ISSN 2320-5407). www.journalijar.com

Dr. Dinesh Roy D
CEO, Genetika, Centre for Advanced Genetic Studies, Pettah P O, Trivandrum - 695024, India

DOI:

Article DOI: 10.21474/IJAR01/9788      
DOI URL: https://dx.doi.org/10.21474/IJAR01/9788

Download Full Paper

Download PDF No. of Downloads: 11 | No. of Views: 72